Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Depreciation and Depletion (2018 - 2025)

Organogenesis Holdings (ORGO) has 8 years of Depreciation and Depletion data on record, last reported at $4.1 million in Q4 2025.

  • For Q4 2025, Depreciation and Depletion rose 12.48% year-over-year to $4.1 million; the TTM value through Dec 2025 reached $15.3 million, up 12.11%, while the annual FY2025 figure was $15.3 million, 12.11% up from the prior year.
  • Depreciation and Depletion reached $4.1 million in Q4 2025 per ORGO's latest filing, up from $4.0 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $4.1 million in Q4 2025 and bottomed at $1.0 million in Q1 2021.
  • Average Depreciation and Depletion over 5 years is $2.5 million, with a median of $2.6 million recorded in 2023.
  • Peak YoY movement for Depreciation and Depletion: soared 102.62% in 2021, then decreased 24.83% in 2022.
  • A 5-year view of Depreciation and Depletion shows it stood at $1.8 million in 2021, then decreased by 14.51% to $1.5 million in 2022, then skyrocketed by 96.96% to $3.0 million in 2023, then rose by 21.23% to $3.6 million in 2024, then grew by 12.48% to $4.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation and Depletion were $4.1 million in Q4 2025, $4.0 million in Q3 2025, and $3.7 million in Q2 2025.